RecruitingPhase 1NCT06961266

A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1

Studying Narcolepsy

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Jazz Pharmaceuticals
Principal Investigator
Global Medical Lead
Jazz Pharmaceuticals
Intervention
JZP441(drug)
Enrollment
8 enrolled
Eligibility
18-64 years · All sexes
Timeline
2025 – 2026

Study locations (4)

Collaborators

Jazz Pharmaceuticals Ireland Limited

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06961266 on ClinicalTrials.gov

Other trials for Narcolepsy

Additional recruiting or active studies for the same condition.

See all trials for Narcolepsy →

← Back to all trials